OBI Pharma Balance Sheet Health
Financial Health criteria checks 3/6
OBI Pharma has a total shareholder equity of NT$3.4B and total debt of NT$57.0M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are NT$4.0B and NT$588.4M respectively.
Key information
1.7%
Debt to equity ratio
NT$57.03m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.41b |
| Equity | NT$3.41b |
| Total liabilities | NT$588.43m |
| Total assets | NT$4.00b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4174's short term assets (NT$1.7B) exceed its short term liabilities (NT$145.2M).
Long Term Liabilities: 4174's short term assets (NT$1.7B) exceed its long term liabilities (NT$443.3M).
Debt to Equity History and Analysis
Debt Level: 4174 has more cash than its total debt.
Reducing Debt: 4174's debt to equity ratio has increased from 1% to 1.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4174 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 4174 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 10.9% each year